These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24638957)

  • 21. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
    Patzold U; Kalies I; Haas J; Ginda EM
    Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
    [No Abstract]   [Full Text] [Related]  

  • 23. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma.
    Ishikawa H; Taniguchi A; Ii Y; Higuchi O; Matsuo H; Nakane S; Asahi M; Niwa A; Tomimoto H
    Neuromuscul Disord; 2017 Oct; 27(10):914-917. PubMed ID: 28694075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment.
    Bradley RJ; Dwyer D; Morley BJ; Robinson G; Kemp GE; Oh SJ
    Prog Brain Res; 1979; 49():441-8. PubMed ID: 515441
    [No Abstract]   [Full Text] [Related]  

  • 25. Bread-and-butter in diagnosis of myasthenia gravis.
    Chan AY; Liu DT
    Arch Neurol; 2005 Dec; 62(12):1939; author reply 1939-40. PubMed ID: 16344357
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Advances in Autoimmune Myasthenia Gravis.
    Punga AR; Kusner L; Berrih-Aknin S; Le Panse R
    Front Immunol; 2020; 11():1688. PubMed ID: 32983085
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibody to acetylcholine receptors in human MG.
    Lindstrom J
    Int J Neurol; 1980; 14(1):17-24. PubMed ID: 6293988
    [No Abstract]   [Full Text] [Related]  

  • 29. The search for new antigenic targets in myasthenia gravis.
    Cossins J; Belaya K; Zoltowska K; Koneczny I; Maxwell S; Jacobson L; Leite MI; Waters P; Vincent A; Beeson D
    Ann N Y Acad Sci; 2012 Dec; 1275():123-8. PubMed ID: 23278587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.
    Huijbers MG; Lipka AF; Plomp JJ; Niks EH; van der Maarel SM; Verschuuren JJ
    J Intern Med; 2014 Jan; 275(1):12-26. PubMed ID: 24215230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis precipitated by trauma: latent myasthenia and the concept of 'threshold'.
    Lane R; Wade J; McGonagle D
    Neuromuscul Disord; 2009 Nov; 19(11):773-5. PubMed ID: 19751977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4.
    Verschuuren JJ; Huijbers MG; Plomp JJ; Niks EH; Molenaar PC; Martinez-Martinez P; Gomez AM; De Baets MH; Losen M
    Autoimmun Rev; 2013 Jul; 12(9):918-23. PubMed ID: 23535160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double seronegative myasthenia gravis with anti-LRP 4 antibodies.
    Zouvelou V; Zisimopoulou P; Rentzos M; Karandreas N; Evangelakou P; Stamboulis E; Tzartos SJ
    Neuromuscul Disord; 2013 Jul; 23(7):568-70. PubMed ID: 23768983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seronegative myasthenia gravis.
    Vincent A; McConville J; Farrugia ME; Newsom-Davis J
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methods for diagnosing seronegative myasthenia gravis].
    Blanco-Hernández T; Navarré-Gimeno A; Brocalero-Camacho A; Cervelló-Donderis A; López-Trigo J; Ortiz-Sánchez P; Sancho-Rieger J
    Rev Neurol; 2008 Mar 16-31; 46(6):360-4. PubMed ID: 18368681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe myasthenia gravis with anti-LRP4 antibodies and Hodgkin lymphoma.
    Hayashi N; Sone J; Fukami Y; Yoshida Y; Kuno S; Shimada K; Atsuta N; Nakamura T; Higuchi O; Katsuno M
    Muscle Nerve; 2021 Jan; 63(1):E2-E4. PubMed ID: 32996610
    [No Abstract]   [Full Text] [Related]  

  • 40. The pathophysiology of penicillamine-induced myasthenia gravis.
    Kuncl RW; Pestronk A; Drachman DB; Rechthand E
    Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.